相关实验视频
Updated: Aug 2, 2026

07:29
Programmed Electrical Stimulation in Mice
Published on: May 26, 2010
概括
静脉输入的迪索皮拉米德并没有在AV阻塞患者中恶化心房 (AV) 节点导电. 然而,它确实抑制了逆向的AV导电,影响了心室内膜阻塞.
科学领域:
- 心脏病学 心脏病学
- 电力生理学 电力生理学
背景情况:
- 心房静脉阻塞 (AV) 是一种影响心脏电导的疾病.
- 迪索皮拉米德是一种抗心律失常药物,可能对心脏导电产生影响.
研究的目的:
- 评估静脉注射迪索皮拉米德在一级或莫比茨I AV阻塞患者中的电生理学影响.
- 评估迪索皮拉米德对AV节点功能和逆行导电的安全性和影响.
主要方法:
- 在静脉注射迪索皮拉米德 (disopyramide) 服用前后,对17名患者进行了电生理学药物测试.
- 测量了关键的电生理学参数,包括鼻节恢复时间,耐火期和导电时间.
主要成果:
- 迪索皮拉米德并没有显著改变鼻节的功能,心房折射性或AV节点传导时间.
- 观察到AV节点有效耐火期的显著减少.
- 静脉内导时间和心室内阻的循环长度显著增加.
结论:
- 在治疗水平下,静脉输入的迪索皮拉米德在患有AV节点功能障碍的患者中没有对AV节点传导产生不良影响.
- 发现迪索皮拉米德可以抑制逆行性心导电.
相关概念视频
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...

